¾ÅÉ«ÊÓƵ
Juliet Gray is a Professor of Paediatric Oncology, working in the Department of Paediatric Oncology at ¾ÅÉ«ÊÓƵ Children's Hospital and the Centre for Cancer Immunology at the ¾ÅÉ«ÊÓƵ. Her main clinical and research interest is in neuroblastoma and cancer immunotherapy. She leads a translational research group focused on the development of novel antibody therapies, and also leads a number of international clinical trials for children with neuroblastoma.
Research
Research groups
Research interests
- Fc modification of monoclonal antibodies to improve effector function
Research projects
Active projects
Researchers:
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Sponsor: Cancer Research UK
Researchers:
Completed projects
Researchers:
Sponsor: Wessex Medical Research
Researchers:
Sponsor: Sparks Children's Medical Research Charity
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Wessex Cancer Trust
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Researchers:
Researchers:
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Sponsor: Neuroblastoma UK
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Cancer Research UK
Researchers:
Sponsor: Children with Cancer UK
Researchers:
Sponsor: Wessex Medical Research
Researchers:
Sponsor: Neuroblastoma UK
Researchers:
Sponsor: Childrens Cancer and Leukaemia Group
Researchers:
Publications
69 publications
Page 5 of 7
DOI:
Type: article
DOI:
Type: review
DOI:
Type: article
DOI:
Type: article
DOI:
Type: article
DOI:
Type: review
Type: patent
DOI:
Type: article
DOI:
Type: article
DOI:
Type: article
External roles and responsibilities
Name:
Member of Scientific Advisory Board, Solving Kids Cancer (External organisation)
Role:
Member
Year:
2017 -
Name:
Member of Executive Commitee European Neuroblastom Reseach Network (SIOPEN) (External organisation)
Role:
Member
Year:
2015 - 2019
Name:
Member of NCRI Childhood Cancer Leukaemia Clinical Study Group (External organisation)
Role:
Member
Year:
2017 -
Name:
Member of CRUK Protocol Safety Review Board (External organisation)
Role:
Member
Year:
2016 -
Name:
Invited expert to NICE Single Technology Appraisal Committee (Anti-GD2 in neuroblastoma) (External organisation)
Role:
Member
Year:
2016 - 2018
Name:
Chair of NCRI CG Neuroblastoma subgroup (External organisation)
Role:
Chair
Year:
2018 -
Name:
Member of national paediatric Experimental Cancer Medicine Centre Steering Group (External organisation)
Role:
Member
Year:
2017 -
Name:
SIOPEN European Neuroblastoma Research Network, Chair of Clinical Trials Committee (External organisation)
Role:
Chair
Year:
2020 -
Name:
Irish Cancer Society (External organisation)
Role:
Member
Year:
2020
Name:
Neuroblastoma Australia - member of Scientific Advisory Board (External organisation)
Role:
Chair
Year:
2019 -
Name:
External examiner MSc in Cancer Immunology and Biotechnology, University of Nottingham
Role:
Examiner
Year:
2018
Name:
Member of National Neuroblastoma Advisory Panel
Role:
Other
Year:
2017
Name:
Thames Valley and Wessex Children's Cancer Operational Delivery Network, Clinical lead
Role:
Other
Year:
2021
Biography
- Early phase immunotherapy trials for neuroblastoma
Prizes
- ‘Outstanding Principal Investigator’ CRN Wessex Awards 2018: (2018)
- Solving Kids Cancer Research Hero (2022)
- ‘Outstanding Principal Investigator’ CRN Wessex Awards 2018: (2018)
- Solving Kids Cancer Research Hero (2022)